[Next-Generation Sequencing Book]
  • [Photo] Gary Van Domselaar • May 26, 2000
    "Actually, the 'Hagahai patent' was not for a gene or genes from the Hagahai people, but for an unusual variant of HIV. The researcher was following NIH policy at the time, which was to patent new discoveries so that NIH could keep them in the public realm and prevent commercialization. This policy has since been reversed and NIH withdrew the patent claim in December 1996. The Hagahai people, both collectively and individually, had approved the taking of samples, and had also, according to the researcher, approved the patent application, in the hope that it would speed research on HIV."

    Full story:
    http://www.genesage.com/professionals/geneletter/archives/controversialattempts.html

    The article is more than a year old but still relevant.

Discussion forums: GeneLetter: Controversial Attempts at Patenting

Expanded view | Monitor forum | Save place

Start a new thread:

You have to be logged in to post a reply.

© 1998-2025 Scilico, LLC. All rights reserved.